Nuclear Medicine and Molecular Imaging Essentials 2017

Session 1: Neuro, Head and Neck

The Evolving Role of PET/CT for Neuroendocrine Tumor Imaging	Daniel Pryma, MD
PET Imaging of Alzheimer’s and Dementia	Ilya Nasrallah, MD, PhD
Diagnosis & Therapy of Hyperthyroidism With Emphasis on Graves Disease	Bennett Greenspan, MD
Thyroid Maliganacy and the ATA guidelines	Kenneth Burman, MD
Thyroid Cancer Guidelines: A Nuclear Medicine Physician’s Case Based Review	Mark Tulchinsky, MD

Session 2: Nuclear Cardiovascular Imaging

Best Practice Cardiac PET in 2017	Manuel Cequeira, MD
F-18 FDG PET/CT Imaging in Cardiac Sarcoidosis: What’s “Hot!”	Gary Dillehay, MD
Cardiac CT and MRI – State of the Art	Charles White, MD
MIBG Imaging in Heart Failure Management	Manuel Cequeira, MD

Session 3: Practice Improvements

The Importance of Advocacy to the Nuclear Medicine Professional	Cindi Luckett-Gilbert, CNMT
PET/CT Coding and Billing: “Am I Coding it Correctly?”	Gary Dillehay, MD
Emergency Preparedness	Craig DeAtley, PA-C

Session 4: Body Imaging

Integrating MRI and PSMA PET Imaging in Prostate Cancer	Peter Choyke, MD
Hepatobiliary Scintigraphy in Chronic Abdominal Pain	Mark Tulchinsky, MD
Glucose Metabolism Changes in Patients With Sepsis on FDG PET	Ghada Issa, MD
The Role of 18F-FDG PET/CT in the Management of Gastric Cancers	Charles Marcus, MD

Session 5: Perspectives and Procedures

18F-FDG-PET Imaging’s Contributions to Medicine	Abass Alavi, MD
SNMMI Background and Agenda	Bennett Greenspan, MD
Unusual Imaging Studies	Mark Crosthwaite, M.Ed, CNMT

Release Date: 5/15/17
CME Expiration: 5/14/20